We then investigated the relationship amongst EFS or OS, selected prognostic clinico-pathological parameters (age at diagnosis, tumor size, primary site, histology, COG risk stratification) and the angiogenic CD105/CD31 ratio. The gene discussed is PECAM1; the disease is neoplasm.